Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Pyoderma gangrenosum (PG) is a rare, autoinflammatory neutrophilic dermatosis that may be triggered by cutaneous trauma and is frequently associated with systemic diseases, most commonly inflammatory bowel disease. Celiac disease (CD), an immune-mediated enteropathy precipitated by gluten, is not typically linked with PG, particularly in the pediatric population. We present a highly unusual case of a 13-year-old female who developed post-surgical PG following excision of an epidermoid cyst, ultimately leading to a new diagnosis of CD. Histopathology and clinical features were consistent with PG, with no evidence of infection. The patient was successfully managed with topical corticosteroids and wound care. Subsequent gastrointestinal evaluation revealed positive celiac serologies and confirmatory duodenal biopsy findings. This case highlights the importance of recognizing PG as a potential cutaneous manifestation of undiagnosed CD in pediatric patients and the need for a multidisciplinary approach to prompt diagnosis and treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12313363PMC
http://dx.doi.org/10.7759/cureus.87137DOI Listing

Publication Analysis

Top Keywords

pyoderma gangrenosum
8
celiac disease
8
post-surgical pyoderma
4
gangrenosum reveals
4
reveals celiac
4
disease pediatric
4
pediatric patient
4
patient pyoderma
4
gangrenosum rare
4
rare autoinflammatory
4

Similar Publications

Aim: To evaluate the therapeutic efficacy and safety of the Janus kinase (JAK) inhibitor tofacitinib in the management of refractory perianal pyoderma gangrenosum (PG) under conditions of baseline immunosuppression and bone marrow suppression.

Methods: We present a 62-year-old male with a 4-month history of painful, progressive symmetrical perianal ulcerations diagnosed as PG, coexisting with condyloma acuminatum. The patient had a background of pure red cell aplasia and myasthenia gravis, and was undergoing chronic immunosuppressive therapy with prednisolone and tacrolimus.

View Article and Find Full Text PDF

Epidemiology and Management for Pediatric Chronic Wounds: A Systematic Review of the Current Literature.

J Surg Res

September 2025

Nationwide Children's Hospital, Abigail Wexner Research Institute, Columbus, Ohio; Department of Plastic and Reconstructive Surgery, Nationwide Children's Hospital, Columbus, Ohio; Pediatric Comprehensive Wound Program, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: Jenny.Barker

Introduction: Chronic wounds affect approximately 10.5 million individuals annually in the United States. Although recent studies have highlighted a surge in chronic wound cases among younger populations, the collective burden of pediatric chronic wounds remains understudied.

View Article and Find Full Text PDF